Financials data is unavailable for this security.
View more
Year on year Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 's net income fell -30.09% from 4.06bn to 2.84bn despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 81.22% to 83.33%.
| Gross margin | 16.23% |
|---|---|
| Net profit margin | 4.01% |
| Operating margin | 4.79% |
| Return on assets | 3.83% |
|---|---|
| Return on equity | 8.06% |
| Return on investment | 7.36% |
More ▼
Cash flow in CNYView more
In 2024, cash reserves at Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd fell by 3.52bn. However, the company earned 3.44bn from its operations for a Cash Flow Margin of 4.59%. In addition the company used 5.96bn on investing activities and also paid 1.01bn in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 26.38 |
|---|---|
| Tangible book value per share | 23.57 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.60 |
|---|---|
| Quick ratio | 1.31 |
| Total debt/total equity | 0.4247 |
|---|---|
| Total debt/total capital | 0.2871 |
More ▼
Growth rates in CNY
SmartText is unavailable
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 43.55% |
| EPS growth(5 years) | -2.32 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -12.77 |
More ▼
